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Summary Immunocytochemical localisation of follicle stimulating hormone (FSH) was carried out in normal,
benign and malignant human prostates by indirect immunoperoxidase technique. Positive staining was
observed in the epithelial cells of all the three categories, while the stromal cells showed a weakly positive
reaction in a few specimens. The brown reaction product was dispersed in the cytoplasm of the epithelial cells.
These observations demonstrate the presence of immunoreactive FSH-like peptide in human prostate. The
significance of FSH in the aetiopathology of prostatic disorders is discussed.
The prostate is now well established as a gland with endo-
crine activity by virtue of the presence in it of a number of
regulatory peptides, such as endorphins (Tsong et al., 1982),
vasopressin and oxytocin (Adashi & Hsueh, 1981), relaxin
(Cameron et al., 1982), somatostatin (Di Sant Agnese & de
Mesy-Jensen, 1984) and inhibin (Sathe et al., 1987; Vanage et
al., 1989). The synthesis of prostatic inhibin, like that of
gonadal inhibin, is under the control of follicle stimulating
hormone (FSH) (Vanage et al., 1989). In view of the large
concentration of inhibin in human prostate (Vaze et al.,
1979), one could speculate regarding the presence of FSH in
human prostate.
The incidence of prostatic disorders (both benign and
malignant) increases with age and circulating FSH levels also
rise in ageing men (Phadke et al., 1987). Whether this in-
creased FSH has any role to play in the pathophysiology of
the prostate needs to be investigated. In this paper, we report
the immunocytochemical localisation of FSH-like peptide in
normal, benign and malignant prostates and the comparative
distribution pattern of immunoreactive FSH in these condi-
tions.
Materials and methods
Prostate specimens, normal (eight), benign prostatic hyper-
plasia (BPH) (25), moderately differentiated carcinoma (12)
and poorly differentiated carcinoma (15) were included in
this study. The tissues were obtained either by trans-urethral
resection or by open prostatectomy. The normal prostate
samples from various age groups (1-60 years) were collected
after autopsy of accident victims from K.E.M. Hospital,
Bombay. A comparative study was carried out on non-
prostatic tissues such as pituitary and testis as positive con-
trols and oesophagus, epididymis, urinary bladder and rec-
tum as negative controls. Six tissues of each category were
examined. Metastatic lymph nodes from four patients with
confirmed primary prostatic carcinoma were included in this
study.
Rabbit anti-human FSH
The anti-serum to FSH used in the present study (NIADDK
anti-FSH-6) was kindly supplied by NIADDK and the
National Hormone Pituitary Program (University of Mary-
land School of Medicine). The reactivity of antiserum to
hFSH with purified hLH, hTSH, hPrl and hGH was at least
1,000 times less than with hFSH. Antiserum to hFSH was
used at a dilution of 1:200 for immunocytochemical studies
for all specimens. Replacement of primary antiserum with
either antigen-absorbed antiserum or normal rabbit serum
(NRS) served as controls for immunocytochemical studies.
Staining method
The sections were stained by an indirect immunoperoxidase
technique. After deparaffinisation, the sections were treated
with a 0.5% solution of 30% hydrogen peroxide. The back-
ground staining was reduced by normal swine serum (1:5).
This step was necessary since it is well known that non-
immunogenic binding of various antisera contributes
significantly to background staining. Rabbit antiserum
against human FSH was applied to the sections for 45 min
followed by peroxidase conjugated swine anti-rabbit
immunoglobulin (Dakopatts) at 1:50 dilution. A thorough
washing of the sections with phosphate buffered saline (PBS),
pH 7.4, was carried out after each step. The peroxidase
reaction was then developed with 3,3'-diamino benzidine tet-
rahydrochloride (Fluka). The sections were counterstained
lightly with haematoxylin and mounted with DPX (Sigma).
Receptor studies
Prostate tissues obtained either by TUR or by open pros-
tatectomy were carried on ice to the laboratory. A
homogenate was prepared using a Polytron homogeniser
(Polytron-kinematica GmbH, PT-10-35) set at the maximum
speed (5 x 1O s at 0C). The receptor preparation was
suspended at a concentration of 2 g in 10 ml of assay buffer
(0.05 M, Tris-buffer, pH 7.5, containing 0.1% BSA, 5 mM
MgCI2 and 0.1 M sucrose).
The testicular receptors were obtained from immature (21-
day-old) Holtzman rats (Reichert & Abou-Issa, 1977). The
receptor preparations were suspended at a concentration of
I g in 10 ml in the assay buffer.
Human FSH (hFSH-13) was iodinated by the chloramine-
T method (Reichert & Bhalla, 1974) with a specific activity of
about 15tCi yg-'.
Binding studies were performed using labelled hFSH (5 ng
hFSH in 50 dl assay buffer) in the presence of serial dilutions
of unlabelled FSH (I -250 ng) with 50 mg of testicular recep-
tor in 500 gl of assay buffer. The total reaction volume was
made up to I ml by addition of assay buffer. The tubes were
then incubated in a metabolic shaker at 37°C for 2 h. Incuba-
tion was terminated by addition of 2 ml of chilled buffer. The
tubes were then centrifuged at 1,500g for 15 min. The super-
natant was discarded by decantation and the tubes were
drained and counted in the well type gamma-counter. The
non-specific binding was determined in presence of a 1000-
fold excess of oFSH (NIH-FSH-S-16).
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Results
The binding of iodinated hFSH to human prostate and rat
testicular membrane was 3% and 10% respectively. However,
only the binding to testicular tissue (positive control) was
specific since it could be displaced by addition of excess cold
FSH. Binding of hFSH to prostatic membrane was non-
specific, since binding was similar in the presence and
absence of cold FSH, indicating a lack of specific receptors
for FSH on prostatic tissue.
Immunohistochemistry
The immunoperoxidase staining indicative of the presence of A immunoreactive FSH was observed in the cytoplasm of the NZ
epithelial cells of the prostate. Positive staining was seen ing
all specimens irrespective of whether these were normal, BPH
or moderately or poorly differentiated adenocarcinomas. The Figure 2 Human testis (a case of Sertoli cell only syndrome).
positive control tissues, both pituitary (Figure 1) and testes Note the positive reaction for FSH in Sertoli and Leydig
(Figure 2), showed immunoperoxidase staining, whereas cells. x 400.
urinary bladder, rectum and oesophagus were unstained.
Normal
All specimens from age 9 years onwards showed positive
staining for FSH in prostatic epithelial cells. However, the
prostate specimens from age I to 8 years were negative for
FSH.
Nodules and tumours
The hyperplastic glands were identified on the basis of a large
number of nodules having papillary epithelial infoldings, stel-
late lumina and mostly double layered epithelial cell lining.
The staining for FSH was intense in these hyperplastic glands
and was localised in the cytoplasm of the columnar epithelial
cells (Figures 3 and 7). The secretory material in the lumen
of the glands showed positive reaction in many of BPH
specimens (Figure 3). In some areas of BPH, an alternating Figure 3 A case of benign of prostatic hyperplasia showing ofecimens positie an. negtie ceas oBserved withina positive immunoperoxidase staining for FSH in the cytoplasm of pattern of positive and negative cells was observed within a epithelial cells. Note the secretory material in the lumen of a few
single gland, indicative of different stages of cell activity. The hyperplastic glands. x 100.
specimens treated with antiserum (absorbed with FSH)
(Figure 4) or normal rabbit serum did not show any staining,
indicative of specificity of the staining for FSH.
Interestingly, in a few cases of BPH as well as malignant
specimens, faint positive reaction was observed in the smooth
muscle bundles of the stromal tissue (Figure 5). In some BPH
specimens, the secretory material was observed in the form of
blobs emerging from the apical portion of the cell (Figure 6).
The intensity of the reaction was varied in moderately
differentiated carcinomas. Epithelial cells of some glands 4
exhibited intense positive reaction while in the adjoining
glands they were faintly stained (Figure 8). The epithelial
cells in poorly differentiated carcinomas also exhibited
marked variation in staining but all specimens examined were
positive for FSH (Figure 9).
Figure 4 BPH section incubated with antiserum absorbed with
FSH, shows negative reaction x 400
Metastasis
Metastatic lymph nodes from four patients with primary
U 7 g y- ^ prostatic tumour were stained. One specimen showed strong
staining for FSH (Figure 10) whereas three other specimens,
although positive, showed only a faint positive reaction
Discussion
Figure I Human pituitary showing positive staining for
FSH. x 100.
Human prostatic endocrine-paracrine cells (amine precusor
uptake and decarboxylation, APUD, cells) were first des-IMMUNOREACTIVE FSH IN HUMAN PROSTATE 227
Figure 5 Benign prostatic hyperplasia showing positive reaction Figure 8 A case of moderately differentiated carcinoma. Some
in smooth muscles of fibroblastic stroma. x 400. glands exhibit intense positive reaction (indicated by arrows)
while the adjoining glands are faintly stained for FSH. x 100.
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Figure 6 The secretroy material coming out of the epithelial cells
in the form of blobs. x 1,000.
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Figure 9 Poorly differentiated carcinoma. Some strongly positive
cells dispersed singly in fibroblastic stroma. x 100.
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Figure 7 High power view of hyperplastic glandular epithelium
showing coarse granules of FSH in the cytoplasm of epithelial
cells of large convoluted glands with double layered epithelial cell
lining. x 400.
cribed by Pretl in 1944 and further studied by Feyrter in
1951. The importance of the prostate gland as an endocrine
organ is supported by the recent identification of several
peptides in this gland, including endorphins (Tsong et al
1982), vasopressin and oxytocin (Adashi & Hsueh, 1981),
relaxin (Cameron et al., 1982), somatostatin (Di Sant Agnese
& de Mesy-Jensen, 1984), inhibin (Sathe et al., 1987; Vanage
et al., 1989) and insulin (Stahler et al., 1988). Contrary to
earlier concepts, it now appears that regulatory peptides are
widely distributed and are involved in various functions that
are beyond those classically recognised for these peptides. In
correlation with this concept, our present study demonstrates
immunocytochemical staining for FSH or FSH-like peptide
Figure 10 Metastatic lymph node from prostatic tumour show-
ing positive reaction for FSH in the epithelial cells. Note the
normal lymphocytes (indicated by arrow) negative for
FSH. x 400.
in epithelial cells of human prostate, whether normal benign
or malignant. The specificity of staining for immunoreactive
FSH is established by positive controls (pituitary and testis)
and negative controls (oesophagus, urinary bladder, rectum
and epididymis). Our findings are in agreement with earlier
observation made by Harper and Griffith (1982), who
reported positive immunocytochemical localisation of FSH in
the prostatic specimens from 11 BPH patients. In the present
study, weakly positive staining of stromal cells was observed
in few specimens from benign and malignant prostates. In
our other studies, we have observed stromal cells showing
strong positive staining for hLH and rather faint in epithelial
cells (unpublished data). In the light of the above observa-228 K.S. HURKADLI et al.
tion, whether the weak immunochemical staining observed
for FSH in stromal cells of some samples is due to a com-
mon alpha-subunit of FSH and LH remains to be deter-
mined.
Epithelial cells from normal prostate showed a positive
reaction, indicating the presence of immunoreactive FSH
during the prepubertal stage. The maximum intensity was
observed in cases of BPH where the staining was granular
and coarse. The blob-like secretion of immunoreactive FSH
often seen in BPH sections provides an explanation for the
presence of FSH in human semen reported earlier (Biswas et
al., 1978; Fossati et al.,1979). In both moderately and poorly
differentiated carcinomas, the positive reaction was focal and
of varied intensity within the same tumour. As compared to
other prostatic antigens, i.e. prostatic acid phosphatase and
prostate specific antigen, we have previously shown that pro-
static inhibin peptide appears to be a vital product as it
persists in epithelial cells of poorly differentiated prostatic
carcinoma when these cells have become negative for the
above mentioned antigens (Sheth et al., 1988). In
confirmation of the relationship of inhibin and FSH, we find
positive cells in all poorly differentiated carcinomas. The
positive staining of immunoreactive FSH in metastatic lymph
nodes with confirmed prostatic carcinoma is indicative of the
spread of prostatic epithelial cells. Pending further studies on
the metastasis of non-prostatic tumours, at the present stage
we do not propose FSH as a specific marker for prostatic
tumour.
The changes in the intensity as well as the pattern observed
for FSH and inhibin (Doctor et al., 1986; Sheth et al., 1987)
were similar. With this knowledge, it is tempting to speculate
that in the prostate FSH plays a regulatory role in inhibin
biosynthesis. This is in agreement with our earlier observa-
tion that exogenous/endogenous FSH is involved in the
modulation of inhibin concentrations of rat prostate (T.R.
Teni et al., in preparation).
Inhibin has been well demonstrated to be involved in
prostatic growth and differentiation by virtue of its effect of
polyamine biosynthesis (Natraj et al., 1986) and
steroidogenesis (Joseph et al., 1987). It is therefore plausible
that FSH, either directly or by modulating inhibin levels,
could be involved in the aetiopathology of the prostate.
Earlier studies in animals indicated that pituitary hormones
could influence prostatic growth and function, since a more
marked atrophy of the rat prostate gland was observed after
hypophysectomy and castration, than after castration alone
(Lostroh et al., 1957). However, information as to which of
the pituitary hormones were involved was not available. It is
likely that among pituitary hormones prolactin, GH and now
FSH may be the hormones related to prostatic dysfunction
and may possibly find clinical application in therapeutic
decisions.
The immunocytochemical identification of FSH-like pep-
tide in the epithelium of prostate tissue could be due either to
circulating FSH bound to specific tissue receptors which then
accumulates intracellularly, or to local production of FSH by
the tissue. Our results, however, indicate a lack of specific
FSH receptors on human BPH tissue. Furthermore, recent
studies carried out by us have revealed the incorporation of
radiolabelled leucine into hFSH which was immuno-
precipitated by specific antisera to hFSH, thus indicating de
novo biosynthesis of FSH by human BPH tissue in an in vitro
system. Hence the high intensity of FSH staining in the
cytoplasm of epithelial cells (particularly in BPH) observed
by us in the present study is due to synthesis and not
internalisation of circulatory FSH. It is therefore worthwhile
to investigate the regulatory mechanism involved in the
biosynthesis of FSH in human prostate. It may be mentioned
that both pituitary and prostate show similar intensity of
FSH staining (antiserum dilution 1:200). It is not yet known
whether FSH synthesised by prostate is bioactive and
physicochemically similar to pituitary FSH. Furthermore,
although prostatic FSH does get secreted in semen (Biswas et
al., 1978; Fossati et al., 1979) it is not yet elucidated whether
or not it enters the circulation. Recently Yoon et al. (1987)
have demonstrated the immunocytochemical localisation of
FSH in human testis. This report supports our findings that
FSH can be synthesised by non-pituitary tissues.
In view of the well established growth regulatory role of
FSH in gonads and its role in modulating inhibin biosyn-
thesis in human prostate glands (Vanage et al., 1989) it
would be of interest to evaluate the autocrine or paracrine
roles of FSH in the aetiopathology of prostatic diseases.
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